Navigation Links
New treatment for babies with sickle cell anemia

Oral liquid hydroxyurea had shown good results when administered to babies with sickle cell// anemia.

Sickle cell anemia is one of the sickle cell disease. A sickle cell disease is often inherited. Sickle cell anemia is the condition where there is anemia and sickle cell hemoglobin is produced. Sickle cells can block small blood vessels and thus can cause damage and pain to the major organs like kidneys, spleen, and brain amongst others.

Researchers of St. Jude Children’s Research Hospital, US, have found out that treating babies with sickle cell anemia with administration of oral liquid hydroxyurea can prevent some of the complications generated by this disease. Hydroxyurea increases the generation of fetal hemoglobin. This can prevent the blood cells from becoming sickle cells. This method of treatment had been used currently to treat adults and older children with the disease.

Researchers have said that short-term liquid hydroxyurea therapy can be safe as well as effective in babies and may be given in increased dosage to young children in the age group of two to five years. The results have shown that after 4years of treatment the concentrations of fetal hemoglobin, hemoglobin and red blood cells have improved significantly in these children.

Reference: Blood, June 2005
'"/>




Page: 1

Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. Now umbilical cord helps in stroke treatment.
4. Now AIDS treatment comes dirt-cheap
5. Breast cancer treatment to be determined by gene test
6. Hemopurifier may revolutionise AIDS treatment
7. New drug helps boost cancer treatment
8. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
9. Experimental treatment for Ebola Virus Shows promising results in mice
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. New dimension in the treatment of female sexual dysfunction
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Moravia Worldwide to Present Live Webinar on Creation and Use of Terminology in Localization 2Health News:Moravia Worldwide to Present Live Webinar on Creation and Use of Terminology in Localization 3Health News:Lung Cancer Alliance Praises Growing National Coalition 2Health News:Lung Cancer Alliance Praises Growing National Coalition 3Health News:Book Offers Help for Parents Struggling with Difficult Teens During the Upcoming Holidays 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 4Health News:Procter & Gamble Announces Appointment of Director 2
Breaking Medicine Technology:Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 2Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 3Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 4Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 5Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 2Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 3Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 4Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 5Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 6Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 2Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 3Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 4Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 5Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 6Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 7Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 8Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 9Three New Studies Give Clear Guidance on How to Better Recruit Volunteers for Alzheimers Clinical Studies 51407 1Three New Studies Give Clear Guidance on How to Better Recruit Volunteers for Alzheimers Clinical Studies 51407 2Three New Studies Give Clear Guidance on How to Better Recruit Volunteers for Alzheimers Clinical Studies 51407 3Three New Studies Give Clear Guidance on How to Better Recruit Volunteers for Alzheimers Clinical Studies 51407 4Three New Studies Give Clear Guidance on How to Better Recruit Volunteers for Alzheimers Clinical Studies 51407 5Brooks Instrument Introduces New Liquid Vaporizer Solutions Breakthrough Vaporization Solutions for All Liquid to vapor Applications 51402 1Brooks Instrument Introduces New Liquid Vaporizer Solutions Breakthrough Vaporization Solutions for All Liquid to vapor Applications 51402 2Brooks Instrument Introduces New Liquid Vaporizer Solutions Breakthrough Vaporization Solutions for All Liquid to vapor Applications 51402 3Federal Bureau of Investigation Awards Lockheed Martin Biometric Card Scanning Service Contract 9225 1Federal Bureau of Investigation Awards Lockheed Martin Biometric Card Scanning Service Contract 9225 2
Other Medicine Technology:Argos Therapeutics Presents Immunosuppression Data for Soluble CD83,at the American Society of Transplantation Congress 2007 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 6Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 7Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 8Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 9Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 10Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 11Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 12